Alnajashi H. Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment. J. Contemp. Med. Sci. [Internet]. 2025 Aug. 26 [cited 2026 May 19];11(4). Available from: https://jocms.org/index.php/jcms/article/view/1916